Affinity, JSW partnership expands reach & services
22-Mar-2010 By Nick Taylor
Affinity Life Sciences and JSW Life Sciences have entered into a strategic partnership to bolster their contract research and manufacturing capabilities.
Dr Reddy’s opens mPEG alcohol plant in Mexico
22-Mar-2010 By Nick Taylor
Dr Reddy’s has made a “significant investment” in an mPEG alcohol production facility in Mexico to strengthen its presence in a sector it believes is on the rise.
Pall teams with Sotax on filters; reports biopharma biz strong in Q2
22-Mar-2010 By Gareth Macdonald
Industrial filtration specialist Pall and testing firm Sotax say their new co-marketing deal is only first stage of planned pharmaceutical industry certification solutions partnership.
NexACT shows preclinical SR potential
18-Mar-2010 By Gareth Macdonald
CRO NexMed says new data from preclinical trials show that its NexACT delivery technology can act as a sustained release “depot” for drugs like insulin and taxol.
Millipore launches Milliflex Quantum for rapid microbial detection
18-Mar-2010 By Gareth Macdonald
Millipore has expanded its microbial detection offering with Milliflex Quantum which, it says, enables manufacturers to respond to contamination issues earlier in the drug and vaccine production process.
Pfizer and Tekirma team on siRNA delivery
17-Mar-2010 By Gareth Macdonald
US drug giant Pfizer will assess Tekimra Pharmaceuticals’s stable nucleic acid-lipid particle (SNALP) platform for the delivery of siRNA drugs.
Compugen creates system to predict peptide delivery
17-Mar-2010 By Nick Taylor
Compugen has developed a computer-based, in silico system which can assist drug delivery research by identifying peptides that have the potential to penetrate cell membranes.
Sigma adds big name small molecules to portfolio in Pfizer deal
15-Mar-2010 By Gareth Macdonald
Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major Pfizer.
China to build ‘one of largest biologics CMOs in Asia’
15-Mar-2010 By Nick Taylor
The Chinese government is supporting a $100m (€73m) project to build a contract biologics production facility in Beijing, which, by some measures, would be the largest in Asia.
Pharmadule providing modular biotech plant to Silcor
10-Mar-2010 By Staff reporter
Pharmadule AB is creating a complete modular biologics production facility, which will be 80 per cent completed in its workshop before delivery, to Lithuania-based Silcor Biotech by 2011.
Glycos scales up sustainable lactic acid production
10-Mar-2010 By Nick Taylor
Glycos Biotechnologies has produced lactic acid in a pilot plant using its sustainable technique, successfully scaling up from a laboratory setting to provide an alternate source for the chiral synthon.
Wacker opens €18m expansion of biologics site
09-Mar-2010 By Nick Taylor
Wacker Chemie AG has expanded its biologics production facility, adding GMP manufacturing capacity and a process development building in response to customer demand.
Synthemax cuts hESC production cost say Geron and Corning
04-Mar-2010 By Gareth Macdonald
New Synthemax synthetic growth matrix promises improved scalability for large-scale hESC production which, say developers Geron and Corning, will cut cost of cell therapy manufacture.
03-Mar-2010 By Gareth Macdonald
The US FDA wants to boost the production of cell-based viral vaccines and says new guidance will help manufacturers.
Asterand gains GLP accreditation at UK laboratory
03-Mar-2010 By Nick Taylor
Asterand has gained GLP accreditation at its UK lab, enabling it to support regulatory submissions and furthering its goal of becoming a fully integrated human tissue service provider.
Covance’s R&D partnership with Lilly expands
01-Mar-2010 By Gareth Macdonald
Covance will provide US drug major Eli Lilly with bioproduct analytical testing services under an expansion of the firms’ year-old R&D collaboration.
Merck KGaA to buy Millipore for €5bn
01-Mar-2010 By Gareth Macdonald
German pharmaceutical firm Merck KGaA says proposed Millipore acquisition will transform its chemicals unit and give it a more balanced business profile.
25-Feb-2010 By Nick Taylor
SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.
Sandoz opens Slovenian biosimilars production plant
25-Feb-2010 By Staff reporter
Lek has opened a 430m² modified protein manufacturing facility in Slovenia to produce epoetin alfa drug substance for use in the biosimilars marketed by its parent company, Sandoz.
Lilly’s Puerto Rico API plant issued with FDA warning letter
24-Feb-2010 By Nick Taylor
The FDA has issued Eli Lilly with a warning letter detailing a significant deviation from cGMP at its API production facility in Puerto Rico, which makes ingredients used in Humalog (insulin lispro), a diabetes treatment.
Dishman teams with Codexis’ for cost saving enzymatic API tech
23-Feb-2010 By Gareth Macdonald
Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.
RecipharmCobra Biologics launches today
22-Feb-2010 By Gareth Macdonald
RecipharmCobra Biologics (RCB) launched today as a specialist biologics contract development and manufacturing organization (CDMO).
H1N1 adjuvants help SAFC in Q4; Sigma sales down in 2009
17-Feb-2010 By Gareth Macdonald
Revenues fell 3 per cent in 2009 at SAFC but pharmaceutical sector demand for vaccine manufacturing products helped firm finish year with six months of growth.
Russia invests in cancer nanodrug capacity and safety
16-Feb-2010 By Gareth Macdonald
Rusnano, the group set up to promote Russia’s nanotechnology infrastructure, says nanodrug development partnership will improve patient access and cut cancer death rates across the country.
Parexel allies with Proteome to boost biomarker offering
15-Feb-2010 By Nick Taylor
Parexel has formed an alliance with Proteome Sciences to enhance its biomarker capabilities, allowing it to help clients make earlier assessments of new compounds in development.
Cali OK for Avrio manufacturing plant
11-Feb-2010 By Staff Reporter
US CDMO Avrio Biopharmaceuticals’ new aseptic fill-and-finish facility in Irvine, California has been approved for the manufacture of biologics by state drug regulators.
MDRNA’s formulation stable after 12 months
09-Feb-2010 By Nick Taylor
MDRNA’s liposomal drug delivery formulation, DiLA2, lost no potency when stored for 12 months in conditions ranging from -80ºC to 4ºC, helping to validate it for administration of UsiRNA.
ISCO stem cell production site passes building inspection
08-Feb-2010 By Nick Taylor
ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products.
Onyx invests in solid-state chemistry offering
04-Feb-2010 By Staff Reporter
UK CRO Onyx Scientific says that new solid state chemistry service will meet growing demand of drug industry “squeezed” by escalating R&D costs.
TTP launches contract screening service
04-Feb-2010 By Nick Taylor
TTP LabTech has launched a contract screening service to assist various aspects of clients’ drug development programmes, from target identification through to preclinical toxicology.
Bioprocessing key to Millipore’s 2009 gains
03-Feb-2010 By Gareth Macdonald
Demand for disposable bioprocessing tech helped Millipore to a comfortable Q4, cementing the recovery made by the unit throughout 2009.
Galapagos buys Argenta to strengthen discovery services
03-Feb-2010 By Nick Taylor
Belgium-based Galapagos NV has acquired Argenta Discovery for €16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of €70m.
Suzhou Eyre cleared for penicillin production by SFDA
Suzhou Erye Pharmaceutical has received SFDA approval to make penicillin at its new manufacturing facility in Eastern China.
Watson buys Eden Biodesign
01-Feb-2010 By Gareth Macdonald
US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.
Therapure rolls-out commercial scale lyophilisation service
01-Feb-2010 By Gareth Macdonald
Therapure Biopharma has added commercial-scale lyophilisation capacity at its facility Mississauga, Ontario in response to growing demand.
Crospon spins out transdermal patch
28-Jan-2010 By Nick Taylor
Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further its development.
Jubilant wins Endo discovery deal extension
27-Jan-2010 By Staff Reporter
Jubilant Biosys has had its drug discovery contract with Endo Pharmaceuticals extended after "early success."
Millipore launches Mycoplasma early-detection system
26-Jan-2010 By Nick Taylor
Detection of Mycoplasma contamination in biologics manufacture can be cut from up to 35 days to four hours using Millipore’s MilliPROBE, according to the company.
Freezer-farm phase of PCT’s cell-therapy plant complete
25-Jan-2010 By Staff Reporter
Work on “freezer farm” phase of Progenitor Cell Therapy’s (PCTs) new manufacturing facility in Allendale, New Jersey is complete.
SurModics opens 90,000 sq ft site
25-Jan-2010 By Nick Taylor
SurModics has opened a 90,000 sq ft cGMP manufacturing and development facility in Birmingham, Alabama, US to support its partnerships and shorten time to market.
Access’ oral insulin shows preclinical promise
20-Jan-2010 By Staff reporter
Access Pharmaceuticals’ insulin diabetes treatment has shown promise in preclinical trials, achieving over 80 per cent oral bioavailability, leading the company to target proof-of-concept studies in humans.
Ranbaxy buys Biovel to strengthen in biologics and vaccines
20-Jan-2010 By Nick Taylor
Ranbaxy Laboratories has strengthened its vaccine and biologics manufacturing capabilities by acquiring India-based Biovel Lifesciences.
AZ looks at Almac’s Flexyte platform for drug discovery
18-Jan-2010 By Gareth Macdonald
UK drug major AstraZeneca will evaluate Almac’s antibody and radiolabelling-free Flexyte kinase assay platform for drug discovery operations.
Cambridge Consultants “invaluable” in deal says Consort Medical
14-Jan-2010 By Staff Reporter
Cambridge Consultants (CC) says experience developing auto-injector technologies was critical to its contract appraisal work during Consort Medical’s £16.8m (€11.5m) takeover of The Medical House (TMH).
Pall buys MRT for mini MTPD technology
13-Jan-2010 By Gareth Macdonald
Pall says its acquisition of MicroReactor Technologies (MRT) broadens its offering in the $1bn (€689m) a year global biopharmaceutical process development market.
Novavax scales up RSV-F vaccine
13-Jan-2010 By Nick Taylor
Novavax has completed cGMP scale up of its RSV-F vaccine candidate, with the material being used in preclinical studies, and amended the terms of the H1N1 collaboration with Xcellerex.
Millipore expands virus filtration range with Viresolve Pro
12-Jan-2010 By Staff Reporter
Millipore wants to help biopharmas address “virus safety challenges” and believes its new Viresolve Pro+ filtration system may provide the solution.
Jubilant partners to expand GPCR screening services
12-Jan-2010 By Staff reporter
Jubilant Biosys has entered into a co-marketing agreement with DiscoveRx, expanding the companies’ screening services and geographic reach.
Genzyme strengthening its quality team and appointments at ISPE and Biogen Idec – People on the move
12-Jan-2010 By Nick Taylor
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its quality team and appointments at ISPE and Biogen Idec.
Florida Biologix expands bioreactor and fill capacity
11-Jan-2010 By Gareth Macdonald
A recently completed manufacturing and filling capacity expansion will help Florida Biologix meet deadlines and win repeat business according to company director Richard Snyder.